Hyaluronic Acid Market Sizeembed
The global hyaluronic acid market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc.
Hyaluronic Acid Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 | Grand View Research, Inc “The global hyaluronic acid market size was valued at USD 8.3 billion in 2018 and is projected to expand at a CAGR of 7.8% over the forecast period.” The global Hyaluronic Acid Market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. Factors, such as increasing concern about toxic chemicals, need for quick and evident results, and shorter recovery time are high impact rendering drivers of this market. The market is witnessing rapid growth due to increasing adoption of aesthetic pr ocedures across the globe. Wide usage of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is driving the market. In addition, increasing cases of obesity indicate a rising number of people suffering from orthopedic disorders, which do not have any permanent cure and the treatments include pain-killers. However, hyaluronic acid-based viscosupplements are expected to be a possible cure for joint pain. Orthovisc, approved in 2013, and Monovisc, approved in 2016, by Anika Therapeutics, Inc. are among the popular viscosupplements. Increasing popularity of cosmetic surgeries across the globe is also expected to boost the market growth. I n 2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging procedure, and filling fine lines. North America led the market in 2018. Presence of key companies, such as Genzyme Corporation and Anika Therapeutics, in this region contributes to market growth. Increasing number of anti-aging procedures performed and resultant demand for dermal fillers are expected to drive the regional market further. Follow Us: To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-market Further key findings from the study suggest: Rising cases of obesity resulting in increased number of cases of osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment According to the studies, the number of people suffering from osteoarthritis is expected to grow from 53 million in 2012 to 78 million by 2040 Asia Pacific is anticipated to emerge as the fastest-growing regional market during the forecast period due to growing geriatric population in China and Japan, which provides a large customer base for antiaging products and services Some of the key companies in the global hyaluronic acid market are F. Hoffmann-La Roche Ltd.; Seikagaku Corp.; Galderma S.A.; Sanofi (Genzyme); Anika Therapeutics, Inc.; Salix Pharmaceuticals; Zimmer Holdings, Inc.; Allergan, Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc Grand View Research has segmented the global hyaluronic acid market on the basis of application and region: Hyaluronic Acid Application Outlook (Revenue, USD Million, 2015 - 2026) Dermal Fillers Osteoarthritis o Single Injection o Three Injection o Five Injection Ophthalmic Vesicoureteral Reflux Hyaluronic Acid Regional Outlook (Revenue, USD Million, 2015 - 2026) North America o U.S. o Canada Europe o Follow Us: U.K. o Germany o France o Italy o Spain Asia Pacific o India o China o Japan Latin America o Brazil o Mexico MEA o Follow Us: South Africa Table of Content of Hyaluronic Acid Market Chapter 1 Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Application 1.1.2 Regional 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 GVR’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details of Primary Research 184.108.40.206 Data for primary interviews in North America 220.127.116.11 Data for primary interviews in Europe 18.104.22.168 Data for primary interviews in Asia Pacific 22.214.171.124 Data for primary interviews in Latin America 126.96.36.199 Data for primary interviews in MEA 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 188.8.131.52 Approach 1: Commodity Flow Approach 1.6.2 Volume Price Analysis (Model 2) 184.108.40.206 Approach 2: Volume Price Analysis 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 List of Abbreviations 1.10 Objectives 1.10.1 Objective 1 1.10.2 Objective 2 Follow Us: Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Segment Outlook 2.2.1 Application 2.2.2 Region 2.2.3 Competitive Insights 2.3 Market Outlook Chapter 3 Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Outlook 3.1.2 Related/Ancillary Market Outlook 3.2 Market segmentation 3.2.1 Market Driver Analysis 3.2.2 Market Restraint Analysis 3.3 Penetration & growth prospect mapping 3.4 Hyaluronic Acid Market Analysis Tools 3.4.1 PEST - SWOT Analysis, By Factor (Political & Legal, Economic And Technological) 3.4.2 Industry Analysis - Porter’s 3.4.3 Major Delas And Strategic Analysis 220.127.116.11 Joint ventures, mergers and acquisition 18.104.22.168 Licensing & partnerships, technology collaborations Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis 4.1 Hyaluronic Acid market: Application Movement Analysis 4.2 Dermal Fillers 4.2.1 Dermal Fillers Market, 2015 - 2026 (USD Million) 4.3 Osteoarthritis 4.3.1 Osteoarthritis Market, 2015 - 2026 (USD Million) 4.3.2 Single Injection 22.214.171.124 Single injection market, 2015 - 2026 (USD Million) 4.3.3 Three Injection 126.96.36.199 Three injection market, 2015 - 2026 (USD Million) Follow Us: 4.3.4 Five Injection 188.8.131.52 Five injection market, 2015 - 2026 (USD Million) 4.4 Ophthalmic 4.4.1 Ophthalmic Market, 2015 - 2026 (USD Million) 4.5 Vesicoureteral reflux 4.5.1 Vesicoureteral reflux Market, 2015 - 2026 (USD Million) Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis 5.1 Hyaluronic Acid Market Share, by Region, 2018 & 2026 5.2 North America 5.2.1 North America Hyaluronic Acid Market, 2015 - 2026 (USD Million) 5.2.2 U.S 184.108.40.206 U.S hyaluronic acid market, 2015 - 2026 (USD Million) 5.2.3 Canada 220.127.116.11 Canada hyaluronic acid market, 2015 - 2026 (USD Million) 5.3 Europe 5.3.1 Europe Hyaluronic Acid Market, 2015 - 2026 (USD Million) 5.3.2 U.K. 18.104.22.168 U.K. hyaluronic acid market, 2015 - 2026 (USD Million) 5.3.3 Germany 22.214.171.124 Germany hyaluronic acid market, 2015 - 2026 (USD Million) 5.3.4 France 126.96.36.199 France hyaluronic acid market, 2015 - 2026 (USD Million) 5.3.5 Italy 188.8.131.52 Italy hyaluronic acid market, 2015 - 2026 (USD Million) 5.3.6 Spain 184.108.40.206 Spain hyaluronic acid market, 2015 - 2026 (USD Million) 5.4 Asia Pacific 5.4.1 Asia Pacific Hyaluronic Acid Market, 2015 - 2026 (USD Million) 5.4.2 India 220.127.116.11 India hyaluronic acid market, 2015 - 2026 (USD Million) 5.4.3 China Follow Us: 18.104.22.168 China hyaluronic acid market, 2015 - 2026 (USD Million) 5.4.4 Japan 22.214.171.124 Japan hyaluronic acid market, 2015 - 2026 (USD Million) 5.5 Latin America 5.5.1 Latin America Hyaluronic Acid Market, 2015 - 2026 (USD Million) 5.5.2 Brazil 126.96.36.199 Brazil hyaluronic acid market, 2015 - 2026 (USD Million) 5.5.3 Mexico 188.8.131.52 Mexico hyaluronic acid market, 2015 - 2026 (USD Million) 5.6 MEA 5.5.1 MEA Hyaluronic Acid Market, 2015 - 2026 (USD Million) 5.5.2 South Africa 184.108.40.206 South Africa hyaluronic acid market, 2015 - 2026 (USD Million) Chapter 6 Reimbursement Scenario 6.1 Reimbursement by Product 6.1.1 Gel-one 6.1.2 EUFLEXXA 6.1.3 Synvisc-One 6.1.4 Supartz 6.1.5 Hyalgan 6.1.6 Monovisc 6.1.7 Orthovisc 6.1.8 Juvéderm, Emervel, Restylane, Macrolane, Belotero, Filorga, Jalupro, Princess, Teosyal, Stylage, Filorga and others 6.2 Reimbursement by Region 6.2.1 U.S. 6.2.2 Canada 6.2.3 China 6.2.4 Japan 6.2.5 India 6.2.6 Brazil Follow Us: 6.2.7 South Africa 6.2.8 Europe Chapter 7 Competitive Landscape 7.1 Recent Developments & Impact Analysis, by Key Market Participants 7.2 Strategy Framework 7.3 Vendor Landscape 7.3.1 List Of Key Distributors And Channel Partners 7.3.2 Strategy Mapping 220.127.116.11 Partnerships 18.104.22.168 Launch of new product 22.214.171.124 Merger & acquisition 126.96.36.199 Geographical expansion 188.8.131.52 Marketing & promotions 7.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength) 7.5 Company Profiles 7.5.1 Allergan 184.108.40.206 Company overview 220.127.116.11 Financial performance 18.104.22.168 Product benchmarking 22.214.171.124 Strategic initiatives 126.96.36.199 SWOT analysis 7.5.2 Sanofi 188.8.131.52 Company overview 184.108.40.206 Financial performance 220.127.116.11 Product benchmarking 18.104.22.168 Strategic initiatives 22.214.171.124 SWOT analysis 7.5.3 Genzyme Corporation 126.96.36.199 Company overview 188.8.131.52 Financial performance Follow Us: 184.108.40.206 Product benchmarking 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis 7.5.4 Anika Therapeutics, Inc. 22.214.171.124 Company overview 126.96.36.199 Financial performance 188.8.131.52 Product benchmarking 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 7.5.5 Salix Pharmaceuticals, Inc. 18.104.22.168 Company overview 22.214.171.124 Financial performance 126.96.36.199 Product benchmarking 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis 7.5.6 Seikagaku Corporation 220.127.116.11 Company overview 18.104.22.168 Financial performance 22.214.171.124 Product benchmarking 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 7.5.7 F. Hoffmann-La Roche AG 184.108.40.206 Company overview 220.127.116.11 Financial performance 18.104.22.168 Product benchmarking 7.5.8 Galderma S.A. 22.214.171.124 Company overview 126.96.36.199 Financial performance 188.8.131.52 Product benchmarking 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis Follow Us: 7.5.9 Zimmer Biomet 18.104.22.168 Company overview 22.214.171.124 Financial performance 126.96.36.199 Product benchmarking 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis 7.5.10 Smith & Nephew Plc 220.127.116.11 Company overview 18.104.22.168 Financial performance 22.214.171.124 Product benchmarking 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 7.5.11 Ferring B.V. 184.108.40.206 Company overview 220.127.116.11 Product benchmarking 18.104.22.168 Strategic initiatives 7.5.12 Lifecore Biomedical, LLC 22.214.171.124 Company overview 126.96.36.199 Financial performance 188.8.131.52 Product benchmarking 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 7.5.13 HTL Biotechnology 18.104.22.168 Company overview 22.214.171.124 Product benchmarking 7.5.14 Shiseido 126.96.36.199 Company overview 188.8.131.52 Financial performance 184.108.40.206 Product benchmarking 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis Follow Us: 7.5.15 Bloomage Freda Biopharm Co. Ltd. 22.214.171.124 Company overview 126.96.36.199 Product benchmarking 188.8.131.52 Strategic initiatives 7.5.16 LG Life Sciences Ltd 184.108.40.206 Company overview 220.127.116.11 Product benchmarking 18.104.22.168 Strategic initiatives 7.5.17 Maruha Nichiro, Inc. 22.214.171.124 Company overview 126.96.36.199 Financial performance 188.8.131.52 Product benchmarking 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 7.5.18 Fluidigm Corporation 18.104.22.168 Company overview 22.214.171.124 Financial performance 126.96.36.199 Product benchmarking 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis Chapter 8 Recommendations Follow Us: About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Follow Us: